Osaic Holdings’s Dianthus Therapeutics DNTH Stock Holding History

Osaic Holdings’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27K	Sell	13 -219	-94%	-$19.1K	﹤0.01%	7416
2026 Q1	$19.5K	Buy	232 +211	+1,005%	+$12.2K	﹤0.01%	5878
2025 Q4	$864	Hold	21	–	–	﹤0.01%	7312
2025 Q3	$717	Buy	21 +14	+200%	+$358	﹤0.01%	7458
2025 Q2	$130	Hold	7	–	–	﹤0.01%	7541
2025 Q1	$126	Hold	7	–	–	﹤0.01%	7212
2024 Q4	$152	Sell	7 -3,105	-100%	-$79.8K	﹤0.01%	7201
2024 Q3	$85.2K	Buy	+3,112	New	+$86.7K	﹤0.01%	4345
2022 Q2	–	Sell	-8	Closed	–	–	7400
2022 Q1	$0	Hold	8	–	–	﹤0.01%	7297
2021 Q4	$1K	Hold	8	–	–	﹤0.01%	7160
2021 Q3	$1K	Buy	+8	New	+$932	﹤0.01%	6999
2021 Q1	–	Sell	-63	Closed	-$8K	–	6827
2020 Q4	$8K	Hold	63	–	–	﹤0.01%	5602
2020 Q3	$7K	Buy	+63	New	+$7.46K	﹤0.01%	5434

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Osaic Holdings's DNTH Position: Q2 2026 in Review

Osaic Holdings reduced its Dianthus Therapeutics (DNTH) stake by 94% in Q2 2026, selling an estimated $19.1K and leaving 13 shares worth $1.27K. The position accounts for ﹤0.01% of the portfolio, ranked #7416.

Osaic Holdings first reported a position in DNTH in Q3 2020 and has held it in 13 quarters since. The position peaked at $85.2K in Q3 2024. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Osaic Holdings held 13 shares of Dianthus Therapeutics worth $1.27K as of Q2 2026.
Osaic Holdings sold 219 Dianthus Therapeutics shares in Q2 2026, an estimated $19.1K.
Dianthus Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7416 holding.
Osaic Holdings first reported a position in Dianthus Therapeutics in Q3 2020 and has held it in 13 quarters since.
Osaic Holdings's Dianthus Therapeutics position peaked at $85.2K in Q3 2024.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.